Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase: Evidence for Reduced Superoxide - Nitric Oxide Interaction

Diabetes

Volumn 53, Issue 3, 2004, Pages 762-768

  DeRubertis, Frederick R ^a,b   Craven, Patricia A ^a   Melhem, Mona F ^a   Salah, Eman M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; COLLAGEN TYPE 4; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIC GMP; GLUCOSE; GLUTATHIONE; INULIN; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GLOMERULUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INULIN CLEARANCE; KIDNEY CORTEX; KIDNEY INJURY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; TRANSGENIC MOUSE; URINARY EXCRETION; WEIGHT GAIN;

ANIMALS; BASE SEQUENCE; CYCLIC GMP; DIABETIC NEPHROPATHIES; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; INULIN; KIDNEY; KIDNEY GLOMERULUS; MICE; MICE, TRANSGENIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; SUPEROXIDES; TRANSFORMING GROWTH FACTOR BETA;

EID: 1442349987     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.3.762     Document Type: Article

References (50)

1. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622, 2002
2. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
3. Baynes J, Thorpe S: The role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-19, 1999
4. Dickinson PF, Carrington AL, Frost GS, Boulton AJM: Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab Res Rev 18:260-272, 2002
5. Melhem MF, Craven PA, Liachenko J, DeRubertis FR: α-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13:108-116, 2002
6. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACE-I and ARB. Kidney Int 61:186-194, 2002
7. Kakimoto M, Inoguchi T, Sona T, Yu HY, Imamura M, Etoh T, Hashimoto T, Hajime N: Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rat. Diabetes 51:1588-1595, 2002
8. Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, Cosso L, Valentini S, Patriarca S, Cottalasso D, Marianari U, Pronzato MA: Comparative trial of N-acetyl-cystein, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 52:499-505, 2003
9. Schleicher E, Wagner E, Nerlich AG: Increased accumulation of the glycooxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457-468, 1997
10. Paolisso G, D'Amore A, Balbi V, Volpe C, Galzerano D, Giugliano D, Sgambato S, Varricchio M, D'Onfrio F: Plasma vitamin C affects glucose homeostasis in healthy subjects and in non insulin dependent diabetes. Am J Physiol 286:E261-E286, 1994
11. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 50:2114-2125, 2001
12. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 54:775-784, 1998
13. U.K. Prospective Diabetes (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
15. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28, 1997
16. Koya D, Lee IK, Ishi H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 8:426-435, 1997
17. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectean AA, Rao PS, Sturman JA, Boles TH, Fu M-X, Baynes J: Taurine ameliorates chronic streptozotocin induced diabetic nephropathy in rats. Am J Physiol 269:F429-F438, 1995
18. Craven P, DeRubertis, Kagan VE, Melhem MF, Studer RK: Effects of dietary supplementation with vitamin C or E on albuminuria, glomerular TGFβ and size in diabetes. J Am Soc Nephrol 8:1405-1407, 1997
19. Craven PA, DeRubertis FR, Melhem M: Nitric oxide in diabetic nephropathy. Kidney Int 52 (Suppl.):S46-S53, 1997
20. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats: evidence for protein kinase C-mediated suppression of the cholinergic response. J Clin Invest 93:311-320, 1994
21. Rosen DR, Siddigue T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX: Mutations in Cu/Zn superoxide dismutase gene are associated with familial. amyotrophic lateral sclerosis. Nature 362:59-62, 1993
22. Schreyer SA, Chua SC Jr, LeBoeuf RC: Obesity and diabetes in a TNF-α receptor-deficient mice. J Clin Invest 102:402-411, 1998
23. Craven PA, Melhem MF, DeRubertis FR: Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int 42:937-946, 1992
24. Kowalski TJ, Liu S-M, Leibel RL, Chua SC: Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes 50:425-435, 2001
25. Hummel KP, Coleman DL: The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. I. C57BL/KsJ and C57BL/6J strains. Biochem Genet 7:1-13, 1972
26. Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, Ziyadeh FN: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. J Clin Invest 95:2338-2345, 1995
27. Melhem MF, Craven PA, DeRubertis FR: Effects of dietary supplementation of α-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12:124-133, 2001
28. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH, Fu MX, Baynes J: Taurine ameliorates chronic streptozotocin induced diabetic nephropathy in rats. Am J Physiol 269:F429-F38, 1995
29. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennie HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
30. Epstein C, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y: Transgenic mice with increased Cu/Zn superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A 84:8044-8048, 1987
31. Fridovich I: Superoxide radical and superoxide dismutases. Annu Rev Biochem 64:97-112, 1995
32. Okado-Matsumoto A, Fridovich I: Subcellular distribution of superoxide dismutases (SOD) in rat liver. J Biol Chem 276:38388-38393, 2001
33. Yamagishi S-I, Edelstein D, Du X-L, Kaneda Y, Guzman M, Brownlee M: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 276:25096-25100, 2001
34. Teixeira H, Schumacher R, Meneghini R: Lower intracellular hydrogen peroxide levels in cells overexpressing CuZn-superoxide dismutase. Proc Natl Acad Sci U S A 95:7872-7875, 1998
35. Liochev SI, Fridovich I: Superoxide and nitric oxide: consequences of varying rates of production and consumption: a theoretical treatment. Free Radic Biol Med 33:137-141, 2002
36. Michiels C, Raes M, Toussaint O, Remacle J: Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17:235-248, 1994
37. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J: Antioxidant defense system in diabetic kidney: a time course study. Life Sci 60:667-679, 1997
38. Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osica TM: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51:3274-3282, 2002
39. Kowluru RA: Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52:818-823, 2003
40. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis ALW, Myatt L: Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 21:1753-1758, 1998
41. Beckman JS, Koppenol WH: Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. Am J Physiology 271:C1424-C1437, 1996
42. Brennan LA, Wedgwood S, Bekker JM, Black SM: The overexpression of copper-zinc superoxide dismutase protects NOS II from nitric oxide-mediated inhibition. DNA Cell Biol 21:827-838, 2002
43. Bank N, Aynedijan HS: Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306-1312, 1993
44. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265:F886-F895, 1993
45. Komers R, Allen TJ, Cooper ME: Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43:1190-1197, 1994
46. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432-438, 1991
47. Hattori Y, Kawasaki H, Abe K, Kanno M: Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094, 1991
48. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide release by glomeruli from diabetic rats. Metabolism 44:695-698, 1995
49. Craven PA, Studer RK, Felder J, Phillips S, DeRubertis FR: Nitric oxide suppresses protein kinase C signalled increases in transforming growth factor β and collagen synthesis induced by glucose in bovine mesangial cells. Diabetes 46:671-681, 1997
50. Studer RK, DeRubertis FR, Craven PA: Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor β and fibronectin synthesis induced by thromboxane. J Am Soc Nephrol 7:999-1005, 1996